600664.SS
600664.SS
CNE0000009T3
HARBIN PHARMACEUTICAL GROUP CO
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
18.61B EUR
8.87B EUR
8.69B EUR
Enterprise Value
17.31B EUR
6.9B EUR
6.5B EUR
Valuation Multiples
Trailing P/E
36.95x
36.8x
29.68x
Forward P/E
24.63x
--
--
Price to Sales
1.15x
0.73x
0.72x
Price to Book
3.05x
1.51x
1.53x
EV/Revenue
1.07x
0.57x
0.54x
EV/EBITDA
19.57x
13.59x
11.47x
Price to FCF (P/FCF)
58.08x
11.2x
16.89x
EV/FCF
54.03x
8.72x
12.63x
FCF Yield
1.72%
8.93%
5.92%
ende